ArticleMolecular biotechnology2026
Cloning and Expression Studies of Osmotin-Like Protein Gene from Solanum nigrum in Escherichia coli.
Article in Molecular biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Plants face various biotic and abiotic stresses, necessitating the activation of defense mechanisms, including pathogenesis-related (PR) proteins. Osmotin-like proteins (OLPs), belonging to the PR-5 family, play a crucial role in plant defense by enhancing resistance to pathogens and environmental stresses. However, the functional characterization of OLPs remains limited. This study aimed to clone and express the OLP gene from the medicinal plant Solanum nigrum in Escherichia coli to facilitate further functional and structural analyses. The genomic DNA of S. nigrum was isolated from in vitro-cultured plants, and the OLP gene was amplified using primers designed via Primer3 software based on NCBI sequences. Gradient PCR optimization determined the optimal annealing temperature between 58.3 °C and 60 °C. The amplified gene was cloned into the pTZ57R/T vector and transformed into E. coli. Sequencing confirmed a 98% homology with reported OLP sequences. For expression analysis, the gene was subcloned into the expression vector pET15b and transformed into E. coli BL21 (DE3). Induction with 1 mM IPTG at 37 °C for 3 h resulted in the production of a 26 kDa protein, confirmed by SDS-PAGE and Protein Dot Blot analysis using anti-histidine antibodies. The successful cloning and expression of OLP provide a foundation for investigating its role in plant-pathogen interactions and its potential applications in agriculture and medicine. This study contributes to understanding PR proteins and offers insights into their potential for enhancing stress tolerance in crops.
Indexed as
Identifiers
40471402What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.